![]() |
Trials |
A douple blind, randomized , two-arm phase 2 study of nivolumab in combination with ipilimumab versus nivolumab in cimbination with ipilimumab placebo in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)Cancer type: Head and Neck cancer Phase: II Principal Investigator: Hernberg Micaela Country: FI Keywords: Finland, Helsinki,nivolumab, ipilimumab Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02823574 |